Item Type | Name |
Concept
|
Arthritis, Rheumatoid
|
Concept
|
Arthritis, Psoriatic
|
Concept
|
Arthritis
|
Academic Article
|
Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis.
|
Academic Article
|
Most patients receiving routine care for rheumatoid arthritis in 2001 did not meet inclusion criteria for most recent clinical trials or american college of rheumatology criteria for remission.
|
Academic Article
|
Quantitative measures for assessing rheumatoid arthritis in clinical trials and clinical care.
|
Academic Article
|
Guidelines for monitoring of methotrexate therapy: "evidence-based medicine" outside of clinical trials.
|
Academic Article
|
Patient questionnaires and formal education level as prospective predictors of mortality over 10 years in 97% of 1416 patients with rheumatoid arthritis from 15 United States private practices.
|
Academic Article
|
Add-on or step-up trials in rheumatoid arthritis: comment on the article by Boers.
|
Academic Article
|
Making an impact on mortality in rheumatoid arthritis: targeting cardiovascular comorbidity.
|
Academic Article
|
Morning stiffness in patients with early rheumatoid arthritis is associated more strongly with functional disability than with joint swelling and erythrocyte sedimentation rate.
|
Academic Article
|
Quantitative measures and indices to assess rheumatoid arthritis in clinical trials and clinical care.
|
Academic Article
|
Continuous indices of core data set measures in rheumatoid arthritis clinical trials: lower responses to placebo than seen with categorical responses with the American College of Rheumatology 20% criteria.
|
Academic Article
|
Patients seen for standard rheumatoid arthritis care have significantly better articular, radiographic, laboratory, and functional status in 2000 than in 1985.
|
Academic Article
|
Preliminary evaluation of a visual analog function scale for use in rheumatoid arthritis.
|
Academic Article
|
Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors.
|
Academic Article
|
The disease activity score is not suitable as the sole criterion for initiation and evaluation of anti-tumor necrosis factor therapy in the clinic: discordance between assessment measures and limitations in questionnaire use for regulatory purposes.
|
Academic Article
|
Radiographic benefit without clinical improvement in infliximab-treated patients with rheumatoid arthritis: comment on the article by Smolen et al.
|
Academic Article
|
A composite disease activity scale for clinical practice, observational studies, and clinical trials: the patient activity scale (PAS/PAS-II).
|
Academic Article
|
The DAS is the most specific measure, but a patient questionnaire is the most informative measure to assess rheumatoid arthritis.
|
Academic Article
|
Changes in Health Assessment Questionnaire disability scores over five years in patients with rheumatoid arthritis compared with the general population.
|
Academic Article
|
An index of patient reported outcomes (PRO-Index) discriminates effectively between active and control treatment in 4 clinical trials of adalimumab in rheumatoid arthritis.
|
Academic Article
|
Advantages and limitations of quantitative measures to assess rheumatoid arthritis: joint counts, radiographs, laboratory tests, and patient questionnaires.
|
Academic Article
|
Why are only 50% of courses of anti-tumor necrosis factor agents continued for only 2 years in some settings? Need for longterm observations in standard care to complement clinical trials.
|
Academic Article
|
Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis.
|
Academic Article
|
Shouldn't standard rheumatology clinical care be evidence-based rather than eminence-based, eloquence-based, or elegance-based?
|
Academic Article
|
Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis.
|
Academic Article
|
N-of-1 trial of low-dose methotrexate and/or prednisolone in lieu of anti-CCP, MRI, or ultrasound, as first option in suspected rheumatoid arthritis?
|
Academic Article
|
QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries.
|
Academic Article
|
Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritis.
|
Academic Article
|
Quantitative measures of rheumatic diseases for clinical research versus standard clinical care: differences, advantages and limitations.
|
Academic Article
|
A three-page Standard Protocol to Evaluate Rheumatoid Arthritis (SPERA) for efficient capture of essential data from patients and health professionals in standard clinical care and clinical research.
|
Academic Article
|
Can a Multi-Dimensional Health Assessment Questionnaire (MDHAQ) and Routine Assessment of Patient Index Data (RAPID) scores be informative in patients with all rheumatic diseases?
|
Academic Article
|
A practical guide to scoring a Multi-Dimensional Health Assessment Questionnaire (MDHAQ) and Routine Assessment of Patient Index Data (RAPID) scores in 10-20 seconds for use in standard clinical care, without rulers, calculators, websites or computers.
|
Academic Article
|
A proposed continuous quality improvement approach to assessment and management of patients with rheumatoid arthritis without formal joint counts, based on quantitative routine assessment of patient index data (RAPID) scores on a multidimensional health assessment questionnaire (MDHAQ).
|
Academic Article
|
Patient questionnaires and formal education as more significant prognostic markers than radiographs or laboratory tests for rheumatoid arthritis mortality--limitations of a biomedical model to predict long-term outcomes.
|
Academic Article
|
Relative efficiencies of physician/assessor global estimates and patient questionnaire measures are similar to or greater than joint counts to distinguish adalimumab from control treatments in rheumatoid arthritis clinical trials.
|
Academic Article
|
Increased augmentation index in rheumatoid arthritis and its relationship to coronary artery atherosclerosis.
|
Academic Article
|
Physical inactivity in patients with rheumatoid arthritis: data from twenty-one countries in a cross-sectional, international study.
|
Academic Article
|
Time to score quantitative rheumatoid arthritis measures: 28-Joint Count, Disease Activity Score, Health Assessment Questionnaire (HAQ), Multidimensional HAQ (MDHAQ), and Routine Assessment of Patient Index Data (RAPID) scores.
|
Academic Article
|
Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study.
|
Academic Article
|
Treatment of rheumatoid arthritis: a global perspective on the use of antirheumatic drugs.
|
Academic Article
|
Are excellent systematic reviews of clinical trials useful for patient care?
|
Academic Article
|
Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countries.
|
Academic Article
|
Amino-terminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritis.
|
Academic Article
|
RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories.
|
Academic Article
|
Limitations of a quantitative swollen and tender joint count to assess and monitor patients with rheumatoid arthritis.
|
Academic Article
|
Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study.
|
Academic Article
|
Erythrocyte sedimentation rate, C-reactive protein, or rheumatoid factor are normal at presentation in 35%-45% of patients with rheumatoid arthritis seen between 1980 and 2004: analyses from Finland and the United States.
|
Academic Article
|
Quantitative clinical rheumatology: "keep it simple, stupid": MDHAQ function, pain, global, and RAPID3 quantitative scores to improve and document the quality of rheumatologic care.
|
Academic Article
|
Declines in erythrocyte sedimentation rates in patients with rheumatoid arthritis over the second half of the 20th century.
|
Academic Article
|
Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis.
|
Academic Article
|
Is a self-report RAPID3 score a reasonable alternative to a DAS28 in usual clinical care?
|
Academic Article
|
Rheumatoid arthritis: strategy more important than agent.
|
Academic Article
|
Quantitative clinical rheumatology: why is a test for anti-CCP antibodies included in most routine care for rheumatoid arthritis while a HAQ/MDHAQ remains largely a research tool?
|
Academic Article
|
Management of associated rheumatoid arthritis and fibromyalgia.
|
Academic Article
|
Can RAPID3, an index without formal joint counts or laboratory tests, serve to guide rheumatologists in tight control of rheumatoid arthritis in usual clinical care?
|
Academic Article
|
Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis.
|
Academic Article
|
Complexities in assessment of rheumatoid arthritis: absence of a single gold standard measure.
|
Academic Article
|
A biopsychosocial model to complement a biomedical model: patient questionnaire data and socioeconomic status usually are more significant than laboratory tests and imaging studies in prognosis of rheumatoid arthritis.
|
Academic Article
|
Joint counts to assess rheumatoid arthritis for clinical research and usual clinical care: advantages and limitations.
|
Academic Article
|
Radiographic measures to assess patients with rheumatoid arthritis: advantages and limitations.
|
Academic Article
|
Laboratory tests to assess patients with rheumatoid arthritis: advantages and limitations.
|
Academic Article
|
Patient questionnaires in rheumatoid arthritis: advantages and limitations as a quantitative, standardized scientific medical history.
|
Academic Article
|
RAPID3, an index to assess and monitor patients with rheumatoid arthritis, without formal joint counts: similar results to DAS28 and CDAI in clinical trials and clinical care.
|
Academic Article
|
A Standard Protocol to Evaluate Rheumatoid Arthritis (SPERA) for efficient capture of essential data from a patient and a health professional in a uniform "scientific" format.
|
Academic Article
|
Criterion contamination of depression scales in patients with rheumatoid arthritis: the need for interpretation of patient questionnaires (as all clinical measures) in the context of all information about the patient.
|
Academic Article
|
RAPID3 (Routine Assessment of Patient Index Data) on an MDHAQ (Multidimensional Health Assessment Questionnaire): agreement with DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) activity categories, scored in five versus more than ninety seconds.
|
Academic Article
|
Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study.
|
Academic Article
|
Comment on: Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis.
|
Academic Article
|
Lipoprotein subclasses determined by nuclear magnetic resonance spectroscopy and coronary atherosclerosis in patients with rheumatoid arthritis.
|
Academic Article
|
2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.
|
Academic Article
|
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.
|
Academic Article
|
The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report.
|
Academic Article
|
American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials.
|
Academic Article
|
American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials.
|
Academic Article
|
RAPID3 (Routine Assessment of Patient Index Data 3) severity categories and response criteria: Similar results to DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) in the RAPID 1 (Rheumatoid Arthritis Prevention of Structural Damage) clinical trial of certolizumab pegol.
|
Academic Article
|
Differences in treat-to-target in patients with rheumatoid arthritis versus hypertension and diabetes--consequences for clinical care.
|
Academic Article
|
Proposed severity and response criteria for Routine Assessment of Patient Index Data (RAPID3): results for categories of disease activity and response criteria in abatacept clinical trials.
|
Academic Article
|
Importance of patient history and physical examination in rheumatoid arthritis compared to other chronic diseases: results of a physician survey.
|
Academic Article
|
Patient self-report RADAI (Rheumatoid Arthritis Disease Activity Index) joint counts on an MDHAQ (Multidimensional Health Assessment Questionnaire) in usual care of consecutive patients with rheumatic diseases other than rheumatoid arthritis.
|
Academic Article
|
An evidence-based medical visit for patients with rheumatoid arthritis based on standard, quantitative scientific data from a patient MDHAQ and physician report.
|
Academic Article
|
Treat-to-target: not as simple as it appears.
|
Academic Article
|
Decline of mean initial prednisone dosage from 10.3 to 3.6 mg/day to treat rheumatoid arthritis between 1980 and 2004 in one clinical setting, with long-term effectiveness of dosages less than 5 mg/day.
|
Academic Article
|
Effective initial and long-term prednisone in doses of less than 5 mg/day to treat rheumatoid arthritis--documentation using a patient self-report Multidimensional Health Assessment Questionnaire (MDHAQ).
|
Academic Article
|
Pragmatic and scientific advantages of MDHAQ/ RAPID3 completion by all patients at all visits in routine clinical care.
|
Academic Article
|
Can remission in rheumatoid arthritis be assessed without laboratory tests or a formal joint count? possible remission criteria based on a self-report RAPID3 score and careful joint examination in the ESPOIR cohort.
|
Academic Article
|
MDHAQ/RAPID3 to recognize improvement over 2 months in usual care of patients with osteoarthritis, systemic lupus erythematosus, spondyloarthropathy, and gout, as well as rheumatoid arthritis.
|
Academic Article
|
GUEPARD treat-to-target strategy is significantly more efficacious than ESPOIR routine care in early rheumatoid arthritis according to patient-reported outcomes and physician global estimate.
|
Academic Article
|
Documenting the value of care for rheumatoid arthritis, analogous to hypertension, diabetes, and hyperlipidemia: is control of individual patient self-report measures of global estimate and physical function more valuable than laboratory tests, radiographs, indices, or remission criteria?
|
Academic Article
|
RAPID3, an index of only 3 patient self-report core data set measures, but not ESR, recognizes incomplete responses to methotrexate in usual care of patients with rheumatoid arthritis.
|
Academic Article
|
Update on methotrexate as the anchor drug for rheumatoid arthritis.
|
Academic Article
|
Efficacy and safety of methotrexate in combination with other non-biologic disease-modifying antirheumatic drugs (DMARDs) in treatment of rheumatoid arthritis.
|
Academic Article
|
Evidence that the strategy is more important than the agent to treat rheumatoid arthritis. Data from clinical trials of combinations of non-biologic DMARDs, with protocol-driven intensification of therapy for tight control or treat-to-target.
|
Academic Article
|
Discordance of global estimates by patients and their physicians in usual care of many rheumatic diseases: association with 5 scores on a Multidimensional Health Assessment Questionnaire (MDHAQ) that are not found on the Health Assessment Questionnaire (HAQ).
|
Academic Article
|
Is a patient questionnaire without a joint examination as undesirable as a joint examination without a patient questionnaire?
|
Academic Article
|
Assessing remission in rheumatoid arthritis on the basis of patient reported outcomes--advantages of using RAPID3/MDHAQ in routine care.
|
Academic Article
|
Are patient self-report questionnaires as "scientific" as biomarkers in "treat-to-target" and prognosis in rheumatoid arthritis?
|
Academic Article
|
Circadian use of glucocorticoids in rheumatoid arthritis.
|
Academic Article
|
Clinical trials documenting the efficacy of low-dose glucocorticoids in rheumatoid arthritis.
|
Academic Article
|
The past versus the present, 1980-2004: reduction of mean initial low-dose, long-term glucocorticoid therapy in rheumatoid arthritis from 10.3 to 3.6 mg/day, concomitant with early methotrexate, with long-term effectiveness and safety of less than 5 mg/day.
|
Academic Article
|
Premature Mortality: A Neglected Outcome in Rheumatic Diseases?
|
Academic Article
|
Rheumatoid arthritis: Predicting mortality in RA: the quest for useful information.
|
Academic Article
|
Discordance of Global Assessments by Patient and Physician Is Higher in Female than in Male Patients Regardless of the Physician's Sex: Data on Patients with Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis from the DANBIO Registry.
|
Academic Article
|
Limitations of clinical trials in chronic diseases: is the efficacy of methotrexate (MTX) underestimated in polyarticular psoriatic arthritis on the basis of limitations of clinical trials more than on limitations of MTX, as was seen in rheumatoid arthritis?
|
Academic Article
|
Prediction of Remission in a French Early Arthritis Cohort by RAPID3 and other Core Data Set Measures, but Not by the Absence of Rheumatoid Factor, Anticitrullinated Protein Antibodies, or Radiographic Erosions.
|
Academic Article
|
Pragmatic assessment of exercise in routine care using an MDHAQ: associations with changes in RAPID3 and other clinical variables.
|
Academic Article
|
Contemporary disease modifying antirheumatic drugs (DMARD) in patients with recent onset rheumatoid arthritis in a US private practice: methotrexate as the anchor drug in 90% and new DMARD in 30% of patients.
|
Academic Article
|
Eligibility of patients in routine care for major clinical trials of anti-tumor necrosis factor alpha agents in rheumatoid arthritis.
|
Academic Article
|
The assessment of rheumatoid arthritis and the acceptability of self-report questionnaires in clinical practice.
|
Academic Article
|
Are long-term very low doses of prednisone for patients with rheumatoid arthritis as helpful as high doses are harmful?.
|
Academic Article
|
Development and validation of the health assessment questionnaire II: a revised version of the health assessment questionnaire.
|
Academic Article
|
Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms.
|
Academic Article
|
Electronic multidimensional health assessment questionnaire (eMDHAQ): past, present and future of a proposed single data management system for clinical care, research, quality improvement, and monitoring of long-term outcomes.
|
Academic Article
|
Electronic eRAPID3 (Routine Assessment of Patient Index Data): opportunities and complexities.
|
Academic Article
|
Limited Value of the Multi-Biomarker Disease Activity Assay Compared to the Routine Assessment of Patient Index Data 3 (RAPID3) Score in the Prognosis of Important Clinical Outcomes in Rheumatoid Arthritis: Comment on the Article by Fleischmann et al and Accompanying Editorial by Davis.
|
Academic Article
|
Implementation of Treat-to-Target in Rheumatoid Arthritis Through a Learning Collaborative: Results of a Randomized Controlled Trial.
|
Academic Article
|
Assessment of pain and other patient symptoms in routine clinical care as quantitative, standardised, "scientific" data.
|
Academic Article
|
Pain and other self-report scores in patients with osteoarthritis indicate generally similar disease burden to patients with rheumatoid arthritis.
|
Academic Article
|
Value of the Routine Assessment of Patient Index Data 3 in Patients With Psoriatic Arthritis: Results From a Tight-Control Clinical Trial and an Observational Cohort.
|
Academic Article
|
In the clinic. Rheumatoid arthritis.
|
Academic Article
|
MDHAQ/RAPID3 scores in patients with osteoarthritis are similar to or higher than in patients with rheumatoid arthritis: a cross-sectional study from current routine rheumatology care at four sites.
|
Academic Article
|
Minimal Clinically Important Improvement of Routine Assessment of Patient Index Data 3 in Rheumatoid Arthritis.
|
Academic Article
|
Diagnosis of Fibromyalgia: Disagreement Between Fibromyalgia Criteria and Clinician-Based Fibromyalgia Diagnosis in a University Clinic.
|
Academic Article
|
Disease Burden in Osteoarthritis Is Similar to That of Rheumatoid Arthritis at Initial Rheumatology Visit and Significantly Greater Six Months Later.
|
Academic Article
|
Osteoarthritis is as severe as rheumatoid arthritis: evidence over 40 years according to the same measure in each disease.
|
Academic Article
|
Functional Status Measures and Indices in Rheumatoid Arthritis: Comment on the Articles by Barber et al and England et al.
|
Academic Article
|
Multidimensional Health Assessment Questionnaire as an Effective Tool to Screen for Depression in Routine Rheumatology Care.
|
Academic Article
|
Comment on: 'It can't be zero!' Difficulties in completing patient global assessment in rheumatoid arthritis: a mixed methods study.
|
Academic Article
|
Long-term Glucocorticoid Use in Rheumatoid Arthritis.
|
Academic Article
|
Should Quantitative Measures and Management of Rheumatoid Arthritis Include More Than Control of Inflammatory Activity?
|
Academic Article
|
Implementing a Treat-to-Target Approach for Rheumatoid Arthritis During the COVID-19 Pandemic: Results of a Virtual Learning Collaborative Program.
|
Academic Article
|
Satisfaction With a Virtual Learning Collaborative Aimed at Implementing Treat-to-Target in Rheumatoid Arthritis.
|
Academic Article
|
Duloxetine may have clinical value: comment on the article by van den Driest et al.
|
Academic Article
|
RheuMetric Quantitative 0 to 10 Physician Estimates of Inflammation, Damage, and Distress in Rheumatoid Arthritis: Validation Against Reference Measures.
|
Academic Article
|
Should quantitative assessment of rheumatoid arthritis include measures of joint damage and patient distress, in addition to measures of apparent inflammatory activity?
|
Academic Article
|
Patient global assessment is elevated by up to 5 of 10 units in patients with inflammatory arthritis who screen positive for fibromyalgia (by FAST4) and/or?depression (by MDS2) on a?single MDHAQ.
|